Piracetam (2-oxo-pyrrolidine acetamide) has been used over the past decade for the management of psychosenescent syndromes. The drug was tentatively suggested by Targino de Araujo and Nero' for the management of sickle cell disease, but their views remain unacknowledged.
Recent clinical trials conducted by Skondia2 and ourselves3 showed that piracetam taken orally (160mg/kg/day, divided in four doses) was a prophylactic treatment for sickle cell vaso-occlusive crises. With maintenance treatment, the number of crises observed was reduced to about one fifth of what would be expected without piracetam.
In this paper we studied the effect of piracetam on sickle cell anaemia (HbSS) red cell deformability in vitro and in vivo by microsieving at pharmacologically obtainable serum concentra.ions.
Material and methods
All tests were carried out on fresh venous blood anticoagulated with 2mg/ml of potassium ethylenediamine-tetraacetate.
Fifteen healthy black subjects with haemoglobin genotype HbAA were studied as controls. Of these, four were children under 10 years of age and 11 were adults aged from 25 to 36 years. The group of seven healthy blacks with haemoglobin genotype AS included four children (6 to 15 years) and three adults.
The group of 15 patients with sickle cell disease included 14 children from 1 to 15 years and one 23
Accepted for publication 29 July 1986 year old woman. All were of the HbSS genotype, except one 10 year old child who had a sickle cell 1 thalassaemia. All the patients were in the steady state and studied as outpatients; they had been asymptomatic for at least three weeks before testing. Haemoglobin genotype was determined by electrophoresis on cellulose acetate using Tris-buffer (pH 8-9). In each carrier of haemoglobin S the following tests were performed: demonstration of sickling by sodium dithionite; percentage of fetal haemoglobin by the "one minute residue" method of Singer; and percentage of A2 haemoglobin by elution of an electrophoresis strip. The parents of each homozygous patient were similarly studied.
MEASUREMENT OF ERYTHROCYTE DEFORMABILITY
A sample of 10ml of venous blood was collected in edetic acid. The filtration experiments were performed within two hours of sampling. After centrifugation at room temperature plasma and buffy coat were discarded and the red cell fraction was washed three times with two volumes of Ringer solution (sodium chloride 147 mmol/l, potassium chloride 2-5 mmol/l, calcium chloride 2-5 mmol/l, human albumin 0-5 g/dl, pH adjusted to 7-4 with 0-3 M Tris).
After the final washing red cells were suspended again in the buffered Ringer solution and the haematocrit adjusted to 1%.
The number of red cells was checked by means of an electronic counter. It After filling the dead space of the assembled filter holder with the cell suspension the holder was mounted on the reservoir and a 5 ml graduated plastic syringe without its plunger mounted on top of the filter. The graduated syringe was filled with the cell suspension up to the 5 ml mark. The reservoir under the filter was put on a negative pressure of 20 cm of water by opening a tap. A stopwatch was started at the same time. The time needed for filtering exactly 5 ml of fluid was used to measure the flow rate through the membrane filter. A new filter of the same batch was used for each measurement, and only filters with a flow rate of 27-30 ml/minute were used. For each determination of index of red cell deformability (IRCD) the respective flow rates of the Ringer solution and of the red cell suspension were successively measured on the same filter.
The IRCD, ranging from 0 to 1, was calculated as follows:
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Results
In a first series of experiments the IRCD was measured without added piracetam. The IRCD and mean (SD) of normal controls (HbAA: 0-92 (0-097)) and heterozygous patients (HbAS: 0-92 (0 073)) were similar. The IRCD and mean (SD) of homozygous HbSS patients was 0 47 (0-13). The difference between the means of HbAA controls and patients with sickle cell anaemia was highly significant (p < 0 001).
In a second series of experiments ( Piracetam has been used extensively over the past decade for the management of the psychosenescent syndrome. It seems to be devoid of severe reactions and toxic effects. Apart from its supposed intrinsic action on the nervous cells, the drug has effects on blood rheology,6 which were discovered recently, Nalbandian et al7 -reported that piracetam had several previously unknown actions on the blood cells. Piracetam seems to be a multitargeted drug, capable of improving the microcirculation by suppressing platelet activity in vivo" "l by enhancing red cell deformability'2 and by reducing the adherence of damaged erythrocytes to endothelial cells. 3 The drug has been reported to be effective for the treatment of patients with sickle cell disease both during crises and as maintenance treatment1 3 7 9 In this report microsieving on polycarbonate membranes was the method chosen to study the influence of piracetam on sickle cell deformability. Microsieving is actually the most available and widely used technique for measuring the HbSS red cell deformability, 14 either in steady state or during a sickle cell crisis.'5 As recommended by Chien, 16 we filtrated the red cells properly. The cells were suspended in an isoosmotic buffered Ringer solution, enriched with serum albumin (0 5 g/dl) to preserve the cell hydration and to avoid crenation. Prior elimination of the buffy coat reduced possible obstruction of the pores by leucocytes. The red cell concentration was adjusted to a constant level. High dilution minimised cell-cell interactions and prevented early saturation of the microsieve.
Our findings in filtrating HbAA-AS-SS cells agree with those of Chien,14 Usami et al,'7 and Lessin et al. 18 These authors, using more elaborated pressure flow filtration systems, showed that red cells of the genotypes HbAA and AS remain roughly identically deformable either when oxygenated or at physiologically reduced oxygen pressure. On the other hand, they observed that HbSS cells, with an already reduced deformability when oxygenated, behave like rigid cells when deoxygenated. Microsieving is also a valuable and sensitive technique for investigating the pathogenesis of sickle cell crisis. Kenny et al '5 showed that a primary loss of deformability occurs during the early stages of the sickle cell crisis. As the rheological properties of HbAS and HbSS cells assessed by microsieving match the clinical observations, microsieving seems to be an appropriate way of studying Gini, Sonnet drug action on sickle cells.
Our experiments have shown that piracetam (1 mmol/l), multiplies the IRCD values of oxygenated HbSS cells by a factor of 1-7. As the reduced deformability of oxygenated HbSS cells cannot be principally ascribed to their low content in viscous deoxyHbS it is likely that piracetam is more effective in improving the membrane flexibility than in reducing the viscosity of the deoxygenated HbS solution within the cell. This view is consistent with the findings of Asakura etal,'9 who in their investigations into the chaotropic properties of the drug, showed that high piracetam concentrations (100 to 600mmol/1) were needed for 50% sickling inhibition in vitro and for prolongation of the gelation time in deoxygenated HbS solutions. Similarly, from our preliminary experiments on filtration of sickled cells in the presence or absence of piracetam, it seems that the chaotropic desickling activity of the drug in the range of the pharmacologically obtainable serum concentrations, is rather poor.
The mechanism of action of piracetam on the viscoelastic properties of the red cell membrane is not known. When studying spectrin by gel filtration chromatography and measuring tetrameric (molecular weight 920000) and dimeric (molecular weight 460000) spectrin concentrations, Vincentelli eta120 found that dimeric spectrin was enhanced by 25% when 1 mmol/l piracetam was present. A possible site of action of piracetam could therefore be the spectrin and actin network, which has a major role in the maintenance of red cell shape and plasticity. 
